Ion Beam Applications SA 2025 IR
The report highlights IBA's strong financial and operational performance in 2025, achieving record-high revenues of EUR 620 million and a return to profitability in its Proton Therapy division. As a certified B Corporation, the company increased its B Corp score to over 118 points and advanced its sustainability agenda, including sourcing over 90% of its electricity from renewable sources. IBA also expanded its strategic footprint in nuclear medicine through the acquisition of ORA Group and continued its progress in climate mitigation and circular economy initiatives.
Company: Ion Beam Applications SA
Sector: Manufacturing
Country: Belgium
Year: 2025
Type: IR
Pages: 271
Back to company
Ion Beam Applications SA
Annual Report
The report highlights IBA's strong financial and operational performance in 2025, achieving record-high revenues of EUR 620 million and a return to profitability in its Proton Therapy division. As a certified B Corporation, the company increased its B Corp score to over 118 points and advanced its sustainability agenda, including sourcing over 90% of its electricity from renewable sources. IBA also expanded its strategic footprint in nuclear medicine through the acquisition of ORA Group and continued its progress in climate mitigation and circular economy initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees